中文簡介

當(dāng)前藥物發(fā)現(xiàn)為發(fā)現(xiàn)界提供了最新、最有見地的評論。該雜志不僅論述了藥物發(fā)現(xiàn)相關(guān)技術(shù)的快速科學(xué)發(fā)展，還論述了管理、商業(yè)和監(jiān)管問題，這些問題在研發(fā)計劃、結(jié)構(gòu)和執(zhí)行過程中日益發(fā)揮作用。特點包括國際專家的評論、重要進(jìn)展的新聞和分析、關(guān)鍵科學(xué)和戰(zhàn)略問題的回顧、特定治療領(lǐng)域最近進(jìn)展的概述和會議報告。覆蓋范圍包括：?新的治療策略?高通量篩選?治療目標(biāo)?組合化學(xué)、并行合成和庫設(shè)計?藥物輸送AdMe/Tox?關(guān)鍵化合物類別和治療領(lǐng)域的進(jìn)展?基因組學(xué)和蛋白質(zhì)組學(xué)?自動化和技術(shù)?虛擬化學(xué)?信息學(xué)?業(yè)務(wù)戰(zhàn)略?臨床試驗以及藥物發(fā)現(xiàn)的其他方面。

投稿網(wǎng)址：http://ees.elsevier.com/drudis/default.asp?acw=3

英文簡介

Drug Discovery Today delivers informed and highly current reviews for the discovery community. The magazine addresses not only the rapid scientific developments in drug discovery associated technologies but also the management, commercial and regulatory issues that increasingly play a part in how R&D is planned, structured and executed.Features include comment by international experts, news and analysis of important developments, reviews of key scientific and strategic issues, overviews of recent progress in specific therapeutic areas and conference reports. Coverage includes: ? Novel therapeutic strategies ? High-throughput screening ? Therapeutic targets ? Combinatorial chemistry, parallel synthesis and library design ? Drug delivery ? ADME/Tox ? Advances in key compound classes and therapeutic areas ? Genomics and proteomics ? Automation and technology ? Virtual chemistry ? Informatics ? Business strategy ? Clinical trials and other aspects of drug discovery.